| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-Fetoprotein by Electroimmunodiffusion
International Agency for Research on Cancer, Lyon, France [P. P. S.], and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20014 [K. R. M., G. L. P.]
The association of
-1-fetoprotein in the serum of patients with primary hepatocellular carcinoma provides another possible parameter for both diagnosis and evaluation of the disease process. A technique for the quantitative measurement of this protein has been devised that uses the method of electroimmunodiffusion. This technique has greater sensitivity and is faster than radial diffusion with antibody in agar. Serums from 75 patients with hepatomas were measured for
-fetoprotein, and these varied from 0.35 to 4950
g/ml.
Received 5/17/71. Accepted 7/20/71.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |